Daniel Spratt MD
Central Nervous System Cancer, Urologic Cancer
Physician
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-1700
Fax+1 216-286-3989
Dr. Spratt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Spratt is a radiation oncologist in Cleveland, OH and is affiliated with UH Cleveland Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He specializes in urologic cancer and is experienced in prostate cancer.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2011 - 2015
Spartanburg Medical CenterInternship, Transitional Year, 2010 - 2011
Vanderbilt University School of MedicineClass of 2010
Certifications & Licensure
OH State Medical License 2021 - 2027
MI State Medical License 2015 - 2022
NY State Medical License 2011 - 2016
SC State Medical License 2010 - 2011
American Board of Radiology Radiation Oncology
Clinical Trials
Publications & Presentations
PubMed
- Death From Infection Among Patients Living With Cancer.Mckenzee Chiam, Kyle Mani, Xi Wang, Ming Wang, Daniel M Trifiletti
American Journal of Clinical Oncology. 2025-04-03 - Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.Amar U Kishan, Yilun Sun, Alison C Tree, Emma Hall, David Dearnaley
The Lancet. Oncology. 2025-04-01 - 1 citationsRacial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.Edward Christopher Dee, Rebecca Todd, Kenrick Ng, Gloryanne Aidoo-Micah, Troy B Amen
Nature Reviews. Urology. 2025-04-01
Press Mentions
Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU SymposiumFebruary 11th, 2025- University Hospitals Seidman Cancer Center Pioneers Use of Varian Ethos 2.0 for Cancer Patient Care in North AmericaJanuary 24th, 2025
- UH Seidman Cancer Center Introduces Advanced Varian Ethos 2.0 for Cancer TreatmentJanuary 23rd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
